enzh-CNfrdeitjakorues

Search

Board of Directors and Management Team

Recce Pharmaceuticals includes a diverse management team of experts in clinical research and business development who are committed to addressing the urgent global health threat posed by antibiotic resistant superbugs and emerging viral pathogens.

Dr John Prendergast

Dr John Prendergast

Non-Executive Chairman
BSc (Hons), MSc (UNSW), PhD (UNSW), CSS (HU)

US based, current Chairman and Co-founder of Palatin Technologies, Inc. (NYSE: PTN) and Lead Director of Heat Biologics, Inc. (NASDAQ: HTBX) – extensive experience in the international commercialisation of pharmaceutical technologies.

James Graham

James Graham

Managing Director &
Chief Executive Officer

B.Com. (Entrepreneurship), GAICD

Five years as former Executive Director and extensive experience in marketing, business development and commercialisation of early-stage technologies with global potential. 

Ms Michele Dilizia

Michele Dilizia

Executive Director &
Chief Scientific Officer

BSc (Med Sci), Grad Dip Bus (Mkting), BA (Journ), GAICD, MASM

Co-inventor and qualified medical scientist; specialisation in medical microbiology and regulatory affairs.

Dr Justin Ward

Dr Justin Ward

Executive Director &
Principal Quality Chemist
BSc (Chem), PhD (Chem), MRACI, CChem

A quality control expert who has worked with leading pharmaceutical companies. He is bringing Recce’s research and development and manufacturing up to US FDA requirements.

Dr Alan Dunton

Non-Executive Director
BSc (BioChem) Hons, M.D. (NYU)

US based, Director of Palatin Technologies. Over three decades of senior pharmaceutical experience incl. President and MD of Janssen Research Foundation (J&J Research). Dr Dunton has advanced a number of blockbuster antibiotics through regulatory review and commercialization at Fortune 500 companies including J&J and Roche.

Arthur Kollaras

Arthur Kollaras

Principal Engineer
BSc, BEng (Chem), PhilEng (Enviro), MIEAust, MISPE

Highly qualified in chemical engineering and microbiology with significant experience taking a new technology concept to pilot plant and full-scale to FDA standards and production internationally.

Daniel Astudillo

Marketing Manager
BCom (Marketing), BA (Spanish), MBA

Experienced marketing specialist in the pharmaceutical and clinical trial sector with expertise in digital marketing campaigns and targeting key investors in the healthcare industry.

Alistair McKeough

Alistair McKeough

Outsourced Company Secretary
Automic Group

Alistair is a qualified lawyer and Principal of Automic Legal. Alistair has broad experience as a commercial litigator and Company Secretary to ASX Listed companies.

Justin Reynolds

Justin Reynolds

Outsourced CFO
Pitcher Partners Sydney

Justin is a qualified accountant and Partner of Pitcher Partners Sydney. Justin has broad experience covering all areas of accounting, taxation and assurance. Particularly, Justin’s areas of expertise are business services and outsourced accounting.

David Bowers

David Bowers

Chair of Clinical Advisory Committee

Leading spinal injury physician at Royal North Shore Hospital. Dr Bowers has a specialist interest in the treatment of complex and life-threatening antibiotic resistant infections, particularly among patients with severe spinal cord injuries.

Professor Philip Sutton

Professor Philip Sutton

Head of Helicobacter pylori Development Program

Global infectious disease expert with over 30 years of research and industry experience, having served as former Head of Immunology at CSL Ltd in Melbourne. Chief Editor of textbook “Helicobacter pylori in the 21st Century” and has co-authored 92 manuscripts published in peer-reviewed journals. Professor Sutton currently leads the Mucosal Immunology Group at Murdoch Children’s Research Institute.

Sign up for news and updates

Receive news and information direct to your inbox.